• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于药物给药的透皮治疗系统

[Transdermal therapeutic systems for drug administration].

作者信息

Hupfeld Stefan, Gravem Hilde

机构信息

Institutt for farmasiDet medisinske fakultetUniversitetet i Tromsø9037 Tromsø.

出版信息

Tidsskr Nor Laegeforen. 2009 Mar 12;129(6):532-3. doi: 10.4045/tidsskr.09.33349.

DOI:10.4045/tidsskr.09.33349
PMID:19282891
Abstract

Transdermal therapeutic systems, or transdermal patches, facilitate controlled release of active ingredients through the skin and into the systemic circulation. Drugs administered through such systems escape first pass metabolism and steady state is maintained similar to a continuous intravenous infusion for up to several days. Few pharmacologically active substances can currently be administered through transdermal patches and production is technically demanding. Research is ongoing to improve the systems and expand the indications. This article gives a brief overview over principles behind various transdermal patch types, as well as the advantages and disadvantages of transdermal therapeutic systems.

摘要

透皮治疗系统,即透皮贴剂,有助于活性成分通过皮肤并进入体循环实现控释。通过此类系统给药的药物可避免首过代谢,并且能维持稳态,类似于持续静脉输注,长达数天。目前,仅有少数药理活性物质可通过透皮贴剂给药,且生产技术要求较高。正在进行相关研究以改进该系统并扩大其适应症。本文简要概述了各种类型透皮贴剂背后的原理,以及透皮治疗系统的优缺点。

相似文献

1
[Transdermal therapeutic systems for drug administration].用于药物给药的透皮治疗系统
Tidsskr Nor Laegeforen. 2009 Mar 12;129(6):532-3. doi: 10.4045/tidsskr.09.33349.
2
Skin tolerability associated with transdermal drug delivery systems: an overview.经皮给药系统的皮肤耐受性:概述。
Adv Ther. 2009 Oct;26(10):920-35. doi: 10.1007/s12325-009-0075-9. Epub 2009 Nov 27.
3
[Transdermal therapeutic systems].[透皮治疗系统]
Eksp Klin Farmakol. 2008 Nov-Dec;71(6):54-7.
4
[Design of transdermal ultrasonophoresis equipment].[经皮超声透药设备的设计]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2009 Feb;26(1):184-6.
5
Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.经皮给药系统(TDDS)的黏附性是一项关键的安全性、有效性和质量属性。
Eur J Pharm Biopharm. 2006 Aug;64(1):1-8. doi: 10.1016/j.ejpb.2006.03.009. Epub 2006 Apr 15.
6
Permeation enhancer strategies in transdermal drug delivery.经皮给药中的渗透促进剂策略。
Drug Deliv. 2016;23(2):564-78. doi: 10.3109/10717544.2014.935532. Epub 2014 Jul 9.
7
Transdermal drug delivery: past progress, current status, and future prospects.经皮给药:过去的进展、现状与未来前景。
Adv Drug Deliv Rev. 2004 Mar 27;56(5):557-8. doi: 10.1016/j.addr.2003.10.021.
8
[Therapeutic systems and drug delivery. 3. Transdermal therapeutic systems].[治疗系统与药物递送。3. 透皮治疗系统]
Lijec Vjesn. 1990 Jul-Aug;112(7-8):235-43.
9
Skin tolerability of transdermal patches.经皮贴片的皮肤耐受性。
Expert Opin Drug Deliv. 2011 Jul;8(7):939-48. doi: 10.1517/17425247.2011.574689. Epub 2011 Apr 21.
10
[Transdermal administration of drugs--are there enough places for patches?].
Duodecim. 1993;109(20):1867-74.

引用本文的文献

1
Strategies for Improving Transdermal Administration: New Approaches to Controlled Drug Release.改善经皮给药的策略:药物控释的新方法。
Pharmaceutics. 2023 Apr 7;15(4):1183. doi: 10.3390/pharmaceutics15041183.
2
Opioid-induced bowel dysfunction: pathophysiology and management.阿片类药物引起的肠道功能紊乱:病理生理学与管理。
Drugs. 2012 Oct 1;72(14):1847-65. doi: 10.2165/11634970-000000000-00000.